Rare Diseases Activities
Advances in Acute Treatment of Acquired Thrombotic Thrombocytopenic Purpura
0290-0000-21-287-H01-P
This activity will review the pathophysiology and diagnosis of TTP, with a focus on available treatments.
1.00
Hereditary Angioedema and the Advances in Treatment to Close the Gaps in Care
0290-0000-21-259-H01-P
This 3-part panel discussion will further examine diagnostic challenges and clinical presentation, specific treatment for different types of HAE, and protocols to facilitate access to new therapies for HAE.
1.50
Advancements in Treating and Managing Long-Chain Fatty Acid Oxidation Disorders, featuring a Patient Perspective
0290-0000-21-217-H01-P
This activity will focus on current treatment options and provide specialty and managed care pharmacists with a better understanding of the management of these rare disorders and their impact on the lives of patients and caregivers through a patient interview.
1.50
The Evolving Treatment Landscape for Neuromyelitis Optica Spectrum Disorder: Updates for Specialty and Infusion Pharmacists
0290-0000-21-218-H01-P
Examine the patient population afflicted with neuromyelitis optica spectrum disorder (NMOSD), including factors related to epidemiology, etiology, pathophysiology, clinical presentation, and diagnostic challenges
1.50